ReviewCureus2022

Benefits of Taking Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease: A Systematic Review.

Aditi Sarker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.